We then filtered the candidates through a list of proteins derived from proteomic profiling of three different GBM cell lines, and further narrowed down SEPT9, SEPT2, WEE1, RPN2, and others as the final candidates (Fig. 1). The gene discussed is SEPTIN2; the disease is glioblastoma.